For: | Fujiki M, Aucejo F, Choi M, Kim R. Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: Where do we stand? World J Gastroenterol 2014; 20(18): 5308-5319 [PMID: 24833861 DOI: 10.3748/wjg.v20.i18.5308] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i18/5308.htm |
Number | Citing Articles |
1 |
Jascha Rubin, Ashwin Sama. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_14-2
|
2 |
Lei Xu, Lin Chen, Wei Zhang. Neoadjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2021; 13(12): 1550-1566 doi: 10.4240/wjgs.v13.i12.1550
|
3 |
Alexander Villalobos, William Wagstaff, Mian Guo, James Zhang, Zachary Bercu, Morgan J. Whitmore, Mircea M Cristescu, Bill S. Majdalany, Joel Wedd, Mehmet Akce, Joseph Magliocca, Marty T. Sellers, Nima Kokabi, Alessandro Granito. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9926704
|
4 |
Jascha Rubin, Ashwin Sama. Contemporary Liver Transplantation. 2017; : 303 doi: 10.1007/978-3-319-07209-8_14
|
5 |
Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio, Giuseppe Mazzarella, Giuseppe Lucio Cascini. Microvascular Invasion in HCC: The Molecular Imaging Perspective. Contrast Media & Molecular Imaging 2018; 2018: 1 doi: 10.1155/2018/9487938
|
6 |
Abu Bakar Hafeez Bhatti, Ammal Imran Qureshi, Rizmi Tahir, Faisal Saud Dar, Nusrat Yar Khan, Haseeb Haider Zia, Shahzad Riyaz, Atif Rana. When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07238-w
|
7 |
Hun Yee Tan, Yin How Wong, Azahari Kasbollah, Mohammad Nazri Md Shah, Basri Johan Jeet Abdullah, Alan Christopher Perkins, Chai Hong Yeong. Development of neutron-activated samarium-153-loaded polystyrene microspheres as a potential theranostic agent for hepatic radioembolization. Nuclear Medicine Communications 2022; 43(4): 410 doi: 10.1097/MNM.0000000000001529
|
8 |
Ruediger E. Schernthaner, Rafael Duran, Julius Chapiro, Zhijun Wang, Jean-François H Geschwind, MingDe Lin. A new angiographic imaging platform reduces radiation exposure for patients with liver cancer treated with transarterial chemoembolization. European Radiology 2015; 25(11): 3255 doi: 10.1007/s00330-015-3717-0
|
9 |
Kohei Ogawa, Yasutsugu Takada. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation. Cancers 2022; 14(2): 396 doi: 10.3390/cancers14020396
|
10 |
Arturo Soriano, Aranzazu Varona, Rajesh Gianchandani, Modesto Enrique Moneva, Javier Arranz, Antonio Gonzalez, Manuel Barrera. Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future. World Journal of Hepatology 2016; 8(1): 58-68 doi: 10.4254/wjh.v8.i1.58
|
11 |
Dagmar Kollmann, Nazia Selzner, Markus Selzner. Bridging to liver transplantation in HCC patients. Langenbeck's Archives of Surgery 2017; 402(6): 863 doi: 10.1007/s00423-017-1609-2
|
12 |
Jascha Rubin, Ashwin Sama. Contemporary Liver Transplantation. 2015; : 1 doi: 10.1007/978-3-319-05543-5_14-1
|
13 |
Stefanie M. Thomas, Diana Moke, Rocio Lopez, Rabi Hanna, Mohammad Nasser Kabbany, Naim Alkhouri. Liver Transplantation for Hepatocellular Carcinoma in Young Adults: A United Network for Organ Sharing Study. Journal of Adolescent and Young Adult Oncology 2017; 6(2): 286 doi: 10.1089/jayao.2016.0048
|
14 |
Guangjiang Jiang, Sunbin Ling, Qifan Zhan, Li Zhuang, Xiao Xu. Downstaging treatment for patients with hepatocelluar carcinoma before transplantation. Transplantation Reviews 2021; 35(2): 100606 doi: 10.1016/j.trre.2021.100606
|
15 |
Michael J. Magnetta, Minzhi Xing, Di Zhang, Hyun S. Kim. The Effect of Bridging Locoregional Therapy and Sociodemographics on Survival in Hepatocellular Carcinoma Patients Undergoing Orthotopic Liver Transplantation: A United Network for Organ Sharing Population Study. Journal of Vascular and Interventional Radiology 2016; 27(12): 1822 doi: 10.1016/j.jvir.2016.07.023
|
16 |
Samdeep K. Mouli, Laura W. Goff. Local Arterial Therapies in the Management of Unresectable Hepatocellular Carcinoma. Current Treatment Options in Oncology 2017; 18(11) doi: 10.1007/s11864-017-0509-6
|
17 |
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, Emmanouil Sinakos. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World Journal of Transplantation 2022; 12(11): 331-346 doi: 10.5500/wjt.v12.i11.331
|
18 |
Danijel Galun, Dragan Basaric, Marinko Zuvela, Predrag Bulajic, Aleksandar Bogdanovic, Nemanja Bidzic, Miroslav Milicevic. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World Journal of Hepatology 2015; 7(20): 2274-2291 doi: 10.4254/wjh.v7.i20.2274
|
19 |
Nicholas Fidelman, Robert K. Kerlan. Transarterial Chemoembolization and 90Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. American Journal of Roentgenology 2015; 205(4): 742 doi: 10.2214/AJR.15.14802
|
20 |
Chun Han Nigel Tan, Yue Yu, Yan Rui Nicholas Tan, Boon Leng Kieron Lim, Shridhar Ganpathi Iyer, Krishnakumar Madhavan, Alfred Wei Chieh Kow. Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?. Annals of Hepato-Biliary-Pancreatic Surgery 2018; 22(1): 27 doi: 10.14701/ahbps.2018.22.1.27
|
21 |
Ka Wing Ma, Tan To Cheung. When to Consider Liver Transplantation in Hepatocellular Carcinoma Patients?. Hepatic Oncology 2017; 4(1): 15 doi: 10.2217/hep-2016-0010
|
22 |
Dimitri Sneiders, Thymen Houwen, Liset H.M. Pengel, Wojciech G. Polak, Frank J. M. F. Dor, Hermien Hartog. Systematic Review and Meta-Analysis of Posttransplant Hepatic Artery and Biliary Complications in Patients Treated With Transarterial Chemoembolization Before Liver Transplantation. Transplantation 2018; 102(1): 88 doi: 10.1097/TP.0000000000001936
|